Spots Global Cancer Trial Database for ascorbic acid
Every month we try and update this database with for ascorbic acid cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma | NCT02168270 | Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... Glioblastoma Gliosarcoma | ascorbic acid temozolomide quality-of-life... laboratory biom... | 19 Years - | University of Nebraska | |
| Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca | NCT01555489 | Stage IV Pancre... | Ascorbic Acid | 18 Years - | Thomas Jefferson University | |
| Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer | NCT05501548 | Prostate Cancer Castration-resi... | Olaparib Vitamin C | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma | NCT02833701 | Glioblastoma Glioma | Ascorbic Acid Bevacizumab Laboratory Biom... Quality-of-Life... | 19 Years - | University of Nebraska | |
| Pharmacological Ascorbate for Lung Cancer | NCT02420314 | Carcinoma, Non-... | Paclitaxel Carboplatin Ascorbic Acid | 18 Years - | University of Iowa | |
| Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer | NCT03175341 | Breast Cancer | Ascorbic Acid Placebos | 18 Years - | Academic Emergency County Hospital Sibiu | |
| High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | NCT03697239 | Metastatic Panc... Pancreatic Canc... Pancreas Cancer Pancreatic Aden... Pancreatic Duct... Pancreatic Meta... | Ascorbic Acid Paclitaxel prot... Cisplatin Gemcitabine | 18 Years - | University of California, San Diego | |
| L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes | NCT00329498 | Acute Myeloid L... Myelodysplastic... | L-Ascorbic Acid | - | Samsung Medical Center | |
| Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients | NCT00661544 | Multiple Myelom... Stem Cell Trans... | Arsenic Trioxid... Melphalan Ascorbic Acid | - 70 Years | M.D. Anderson Cancer Center | |
| A Research Trial of High Dose Vitamin C and Chemotherapy for Metastatic Pancreatic Cancer | NCT01049880 | Pancreatic Neop... | Gemcitabine wit... | 18 Years - | University of Iowa | |
| Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) | NCT03410030 | Pancreatic Canc... Pancreas Cancer Pancreatic Aden... Pancreatic Duct... Pancreas Metast... | Ascorbic Acid Paclitaxel prot... Cisplatin Gemcitabine | 18 Years - | HonorHealth Research Institute | |
| Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma | NCT02833701 | Glioblastoma Glioma | Ascorbic Acid Bevacizumab Laboratory Biom... Quality-of-Life... | 19 Years - | University of Nebraska | |
| A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme | NCT01752491 | Glioblastoma GBM Glioblastoma Mu... | Ascorbate Temozolomide Radiation thera... | 18 Years - | University of Iowa | |
| Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma | NCT00112879 | Stage I Multipl... Stage II Multip... Stage III Multi... Refractory Plas... | arsenic trioxid... ascorbic acid dexamethasone thalidomide anti-cytokine t... antiangiogenesi... biological ther... chemotherapy drug resistance... growth factor a... non-specific im... | 18 Years - | National Cancer Institute (NCI) | |
| Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma | NCT02168270 | Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... Glioblastoma Gliosarcoma | ascorbic acid temozolomide quality-of-life... laboratory biom... | 19 Years - | University of Nebraska | |
| A Research Trial of High Dose Vitamin C and Chemotherapy for Metastatic Pancreatic Cancer | NCT01049880 | Pancreatic Neop... | Gemcitabine wit... | 18 Years - | University of Iowa | |
| Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis | NCT01014546 | Essential Throm... Polycythemia Ve... Primary Myelofi... | Arsenic Trioxid... Ascorbic Acid Laboratory Biom... Pharmacological... | 19 Years - | Roswell Park Cancer Institute | |
| A Phase Ib Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations | NCT03433781 | Myelodysplastic... | Vitamin C | 18 Years - | NYU Langone Health | |
| High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | NCT03697239 | Metastatic Panc... Pancreatic Canc... Pancreas Cancer Pancreatic Aden... Pancreatic Duct... Pancreatic Meta... | Ascorbic Acid Paclitaxel prot... Cisplatin Gemcitabine | 18 Years - | University of California, San Diego | |
| Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery | NCT02896907 | Pancreatic Aden... Recurrent Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa... | Oxaliplatin Irinotecan Hydr... Leucovorin Calc... Fluorouracil Ascorbic Acid | 18 Years - 75 Years | Thomas Jefferson University | |
| Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer | NCT05849129 | Lung Cancer | Ascorbic acid Normal Saline | 18 Years - | The Canadian College of Naturopathic Medicine | |
| Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis | NCT01014546 | Essential Throm... Polycythemia Ve... Primary Myelofi... | Arsenic Trioxid... Ascorbic Acid Laboratory Biom... Pharmacological... | 19 Years - | Roswell Park Cancer Institute | |
| Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia | NCT03418038 | Clonal Cytopeni... High Grade B-Ce... Recurrent Diffu... Recurrent Hodgk... Recurrent Lymph... Refractory Diff... Refractory Lymp... Chronic Myelomo... | Ascorbic Acid Carboplatin Cisplatin Cytarabine Dexamethasone Etoposide Gemcitabine Hyd... Ifosfamide Laboratory Biom... Oxaliplatin Placebo Adminis... Questionnaire A... Rituximab Decitabine Biospecimen Col... Core Biopsy Bone Marrow Asp... Bone Marrow Bio... Echocardiograph... Positron Emissi... Magnetic Resona... Central Venous ... Portacath Place... Computed Tomogr... | 18 Years - | Mayo Clinic | |
| Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis | NCT01014546 | Essential Throm... Polycythemia Ve... Primary Myelofi... | Arsenic Trioxid... Ascorbic Acid Laboratory Biom... Pharmacological... | 19 Years - | Roswell Park Cancer Institute | |
| Plasmatic L-AScorbic Acid in MYelodyplastic Syndroms and Controls | NCT02809222 | Myelodysplastic... Secondary Acute... | Samples Quality of life... | 60 Years - | University Hospital, Tours | |
| Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients | NCT04046094 | Bladder Cancer | Ascorbic Acid | 18 Years - | University of Kansas Medical Center | |
| Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma | NCT00006021 | Multiple Myelom... | ascorbic acid arsenic trioxid... | 18 Years - 120 Years | University of Miami | |
| Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma | NCT00227682 | Multiple Myelom... | ascorbic acid arsenic trioxid... dexamethasone thalidomide | 18 Years - | OHSU Knight Cancer Institute | |
| Combining Active and Passive DNA Hypomethylation | NCT03999723 | Myelodysplastic... Acute Myeloid L... Chronic Myelomo... | Vitamin C Placebo | 18 Years - | Rigshospitalet, Denmark | |
| Clinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer | NCT01515046 | Pancreatic Neop... Pancreatic Canc... | Gemcitabine wit... | 18 Years - | University of Iowa | |
| Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca | NCT01555489 | Stage IV Pancre... | Ascorbic Acid | 18 Years - | Thomas Jefferson University | |
| High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | NCT03908333 | Metastatic Panc... Pancreatic Canc... Pancreas Cancer Pancreatic Aden... Pancreatic Duct... Pancreatic Meta... | Ascorbic Acid Paclitaxel prot... Cisplatin Gemcitabine | 18 Years - | Medical College of Wisconsin | |
| Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer | NCT03175341 | Breast Cancer | Ascorbic Acid Placebos | 18 Years - | Academic Emergency County Hospital Sibiu | |
| Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer | NCT02516670 | Hormone-Resista... Metastatic Pros... Stage IV Prosta... | Ascorbic Acid Docetaxel Laboratory Biom... Pharmacological... Placebo Quality-of-Life... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma | NCT02833701 | Glioblastoma Glioma | Ascorbic Acid Bevacizumab Laboratory Biom... Quality-of-Life... | 19 Years - | University of Nebraska | |
| High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | NCT03908333 | Metastatic Panc... Pancreatic Canc... Pancreas Cancer Pancreatic Aden... Pancreatic Duct... Pancreatic Meta... | Ascorbic Acid Paclitaxel prot... Cisplatin Gemcitabine | 18 Years - | Medical College of Wisconsin | |
| Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia | NCT00258245 | Multiple Myelom... | ascorbic acid arsenic trioxid... bortezomib dexamethasone thalidomide Aspirin | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Vitamin C Intravenously With Chemotherapy in Advanced Colorectal Cancer | NCT02969681 | Colorectal Neop... | ascorbic acid Chemotherapy | 18 Years - 75 Years | Sun Yat-sen University | |
| Effect of Vitamin C on Postoperative Pulmonary Complications After Intracranial Tumor Surgery | NCT06421688 | Ascorbic Acid Neurosurgical P... Humans Ventilator-Indu... Postoperative C... | Ascorbic acid Saline | 18 Years - 75 Years | Qianfoshan Hospital | |
| Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma | NCT01715597 | Uterine Leiomyo... | ascorbic acid Normal saline | - | Seoul National University Hospital | |
| Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease | NCT01125449 | Sarcoma Adenocarcinoma Carcinoma Multiple Myelom... Desmoplastic Sm... | Ascorbic acid (... | 18 Years - | Situs Cancer Research Center | |
| High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | NCT03697239 | Metastatic Panc... Pancreatic Canc... Pancreas Cancer Pancreatic Aden... Pancreatic Duct... Pancreatic Meta... | Ascorbic Acid Paclitaxel prot... Cisplatin Gemcitabine | 18 Years - | University of California, San Diego | |
| Vitamin C Intravenously With Chemotherapy in Advanced Colorectal Cancer | NCT02969681 | Colorectal Neop... | ascorbic acid Chemotherapy | 18 Years - 75 Years | Sun Yat-sen University | |
| Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer | NCT02521077 | Fatigue | Ascorbic Acid Normal Saline | 18 Years - | Midwestern Regional Medical Center | |
| High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | NCT03797443 | Metastatic Panc... | Ascorbic Acid nab paclitaxel Cisplatin Gemcitabine | 18 Years - | Piedmont Cancer Institute | |
| Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease | NCT01125449 | Sarcoma Adenocarcinoma Carcinoma Multiple Myelom... Desmoplastic Sm... | Ascorbic acid (... | 18 Years - | Situs Cancer Research Center | |
| Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients | NCT00661544 | Multiple Myelom... Stem Cell Trans... | Arsenic Trioxid... Melphalan Ascorbic Acid | - 70 Years | M.D. Anderson Cancer Center | |
| The Effectiveness of High-dose Intravenous Vitamin c With Very Low Carbohydrate Diet for Terminal Colon Cancer Patients | NCT04035096 | Colon Cancer St... | Ascorbic Acid Control group | 20 Years - | National Taiwan University Hospital | |
| Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) | NCT03410030 | Pancreatic Canc... Pancreas Cancer Pancreatic Aden... Pancreatic Duct... Pancreas Metast... | Ascorbic Acid Paclitaxel prot... Cisplatin Gemcitabine | 18 Years - | HonorHealth Research Institute | |
| Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients | NCT00469209 | Myeloma | Trisenox (Arsen... Velcade (Bortez... Melphalan Vitamin C (Asco... | - 75 Years | M.D. Anderson Cancer Center | |
| Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA | NCT01550510 | Stage IV Colore... | Ascorbic Acid Irinotecan | 18 Years - | Thomas Jefferson University | |
| TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid | NCT03397173 | Myelodysplastic... Myeloproliferat... Acute Myeloid L... | Azacitidine Ascorbic acid | 18 Years - | Case Comprehensive Cancer Center | |
| Effect of Vitamin C in Autologous Stem Cell Transplantations | NCT03964688 | Myeloma Multipl... Lymphoma | Vitamin C Placebos | 18 Years - | Maastricht University Medical Center | |
| Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma | NCT00317811 | Multiple Myelom... | ascorbic acid bortezomib melphalan | 18 Years - | National Cancer Institute (NCI) | |
| Pharmacological Ascorbate for Lung Cancer | NCT02420314 | Carcinoma, Non-... | Paclitaxel Carboplatin Ascorbic Acid | 18 Years - | University of Iowa | |
| Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I | NCT01852890 | Pancreatic Neop... | Ascorbate Gemcitabine Radiation thera... | 18 Years - | University of Iowa | |
| Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer | NCT05849129 | Lung Cancer | Ascorbic acid Normal Saline | 18 Years - | The Canadian College of Naturopathic Medicine | |
| Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery | NCT03334409 | Clear Cell Rena... Metastatic Clea... Stage III Renal... Stage IV Renal ... Unresectable Re... | Ascorbic Acid Pazopanib Hydro... | 18 Years - | Academic and Community Cancer Research United | |
| Trial of Chemotherapy Plus Intravenous Vitamin C in Patients With Advanced Cancer for Whom Chemotherapy Alone is Only Marginally Effective | NCT01050621 | Cancer | vitamin C (asco... | 18 Years - | Jewish General Hospital | |
| Ascorbic Acid Levels in MDS, AML, and CMML Patients | NCT03526666 | Myelodysplastic... Acute Myeloid L... Chronic Myelomo... MDS AML CMML | Peripheral bloo... | 18 Years - | Van Andel Research Institute | |
| High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | NCT03797443 | Metastatic Panc... | Ascorbic Acid nab paclitaxel Cisplatin Gemcitabine | 18 Years - | Piedmont Cancer Institute | |
| A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) | NCT02905578 | Pancreatic Neop... Cancer of Pancr... Cancer of the P... Neoplasms, Panc... Pancreas Cancer Pancreas Neopla... Adenocarcinoma | Gemcitabine nab-paclitaxel Pharmacological... | 18 Years - | University of Iowa | |
| Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I | NCT01852890 | Pancreatic Neop... | Ascorbate Gemcitabine Radiation thera... | 18 Years - | University of Iowa | |
| Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia | NCT00184054 | Acute Myelogeno... | Arsenic Trioxid... Ascorbic Acid | 18 Years - | University of Southern California | |
| Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia | NCT03418038 | Clonal Cytopeni... High Grade B-Ce... Recurrent Diffu... Recurrent Hodgk... Recurrent Lymph... Refractory Diff... Refractory Lymp... Chronic Myelomo... | Ascorbic Acid Carboplatin Cisplatin Cytarabine Dexamethasone Etoposide Gemcitabine Hyd... Ifosfamide Laboratory Biom... Oxaliplatin Placebo Adminis... Questionnaire A... Rituximab Decitabine Biospecimen Col... Core Biopsy Bone Marrow Asp... Bone Marrow Bio... Echocardiograph... Positron Emissi... Magnetic Resona... Central Venous ... Portacath Place... Computed Tomogr... | 18 Years - | Mayo Clinic | |
| Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes | NCT00803530 | Myelodysplastic... | ATO + Ascorbic ... | 18 Years - 80 Years | Fondazione Italiana Sindromi Mielodisplastiche-ETS | |
| Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer | NCT05849129 | Lung Cancer | Ascorbic acid Normal Saline | 18 Years - | The Canadian College of Naturopathic Medicine | |
| A Phase Ib Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations | NCT03433781 | Myelodysplastic... | Vitamin C | 18 Years - | NYU Langone Health | |
| Study of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid Tumors | NCT00441207 | Cancer | Ascorbic Acid | 18 Years - | Midwestern Regional Medical Center | |
| Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers | NCT02868151 | Oral Mucositis | Ascorbic Acid Zinc acetate | 18 Years - | Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre | |
| Plasmatic L-AScorbic Acid in MYelodyplastic Syndroms and Controls | NCT02809222 | Myelodysplastic... Secondary Acute... | Samples Quality of life... | 60 Years - | University Hospital, Tours | |
| IV Ascorbic Acid in Advanced Gastric Cancer | NCT03015675 | Gastric Cancer | ascorbic acid mFOLFOX6 | 18 Years - 75 Years | Sun Yat-sen University | |
| Comparison of Low Volume PEG-Asc and Lower Volume PEG-Asc With Bisacodyl | NCT02980562 | Bowel Disease Colon Adenoma | Polyethylene Gl... Bisacodyl | 20 Years - 75 Years | Korea University Anam Hospital | |
| Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes | NCT00803530 | Myelodysplastic... | ATO + Ascorbic ... | 18 Years - 80 Years | Fondazione Italiana Sindromi Mielodisplastiche-ETS | |
| Vitamin C as an Anti-cancer Drug | NCT01080352 | Prostatic Neopl... | Ascorbic Acid (... | 18 Years - | Copenhagen University Hospital at Herlev | |
| Comparison of Low Volume PEG-Asc and Lower Volume PEG-Asc With Bisacodyl | NCT02980562 | Bowel Disease Colon Adenoma | Polyethylene Gl... Bisacodyl | 20 Years - 75 Years | Korea University Anam Hospital | |
| Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA | NCT01550510 | Stage IV Colore... | Ascorbic Acid Irinotecan | 18 Years - | Thomas Jefferson University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
